30
Participants
Start Date
April 30, 2004
Primary Completion Date
September 30, 2005
Study Completion Date
March 31, 2006
Oxaliplatin
"Oxaliplatin will be administered at the dose of 130 mg/m2 given as a 2 hour intravenous infusion on day 1 of a three week cycle, prior to the 1st dose of capecitabine. 5-HT3 antagonists with or without dexamethasone premedication are strongly recommended. Oxaliplatin may be infused either through a peripheral vein or a central venous line. The infusion lines must be adequately flushed with 5% dextrose solution (D5W) between oxaliplatin infusion \& the administration of any other drug.~Capecitabine is to be administered orally within 30 mins. after the end of a meal. Tablets should be swallowed with approximately 200 mL water (not fruit juices). The first dose of each cycle will be administered as the evening dose on day 1 \& the last dose of each cycle is scheduled the morning of day 15, followed by a 7 day rest period. This provides for a total of 28 single doses per cycle over 15 calendar days."
Lovelace Sandia Health Systems Dept of Hematology, Albuquerque
University of New Mexico Cancer Center, Albuquerque
Hematology Oncology Associates, Albuquerque
New Mexico Veterans Administration Health Care System, Albuquerque
New Mexico Cancer Research Alliance
OTHER